Skip to main content
In stock | Targeted Therapy

Tazemetostat

Oncology Type Hematologic
Drug Class / Mechanism EZH2 / Menin Inhibitor
No Image
Description

Tazemetostat is classified as an EZH2 / Menin Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy
Oncology Type Hematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3